4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2
Titel:
4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2
Auteur:
Taplin, M.E. Chi, K.N. Chu, F. Cochran, J. Edenfield, W.J. Antonarakis, E.S. Emmenegger, U. Heath, E.I. Hussain, A. Njar, V.C. Koletsky, A. Lipsitz, D. Nordquist, L. Pili, R. Rettig, M. Sartor, O. Shore, N.D. Marrinucci, D. Mamlouk, K. Montgomery, B.